ICD-10 Code R61: Generalized hyperhidrosis diagnosis guide

Key Takeaways

ICD-10 Code R61 (generalized hyperhidrosis) is a billable ICD-10-CM diagnosis code valid for insurance claim submission in the US (confirmed FY2024-FY2026).

R61 covers generalized excessive sweating and diaphoresis. Focal hyperhidrosis maps to the L74.5x subcategory instead, not R61.

When an underlying cause (menopause, medication, infection) is identified, sequence the etiology code first and R61 as a secondary code.

Pabau’s built-in ICD-10 code search and documentation templates help dermatology and skin care practices reduce R61 coding errors and support medical necessity.

ICD-10 Code R61 is the billable ICD-10-CM diagnosis code for generalized hyperhidrosis: excessive, body-wide sweating that is not confined to a single anatomical site. It is frequently confused with the L74.5x focal hyperhidrosis subcodes, and mismatching the axilla, face, palm, and sole subcodes is one of the most common billing errors in hyperhidrosis claims.

ICD-10 Code R61: Quick reference

Claims billed under ICD-10 Code R61 get denied more often than coders expect, because the boundary between R61 (generalized) and L74.5x (focal) is easy to miss under time pressure. The Centers for Medicare and Medicaid Services (CMS) confirmed R61 as a valid billable code for FY2024 through FY2026, but correct documentation and code selection remain the practitioner’s responsibility.

This guide covers the R61 code definition, its clinical scope, the R61 vs L74.5 distinction, CPT pairings for hyperhidrosis treatment billing, and the documentation a payer needs to approve the claim.

What does ICD-10 Code R61 mean?

ICD-10 Code R61 describes generalized hyperhidrosis: excessive sweating that is body-wide rather than confined to a discrete anatomical site. Clinically, it covers presentations documented as diaphoresis, profuse generalized perspiration, or night sweats where no focal pattern is identified and no definitive underlying cause has been established in the record.

The eccrine sweat glands, distributed across the entire skin surface, drive the mechanism. When central thermoregulatory or autonomic nervous system signals produce sweating disproportionate to the physiological stimulus, the presentation qualifies as generalized hyperhidrosis. Practices managing these patients, particularly skin clinic software users, frequently encounter R61 as the lead or secondary diagnosis code.

• Generalized: sweating affects multiple body regions simultaneously, not an isolated site
• Excessive: sweating exceeds what normal thermoregulation or emotional stimulus requires
• No focal pattern: if the patient sweats only from the axillae, palms, or face, L74.5x is more specific
• Clinical synonyms accepted: diaphoresis, profuse sweating, excessive perspiration (generalized)

R61 sits in the ICD-10-CM chapter for symptoms and signs (Chapter 18: R00-R99). It is a symptom code, not a disease-level code, which has direct implications for sequencing when an underlying cause is identified.

R61 code details and clinical description

R61 carries no subcategory subdivisions in ICD-10-CM. It is a single-level billable code with no child codes, which simplifies selection but also means coders must rely on clinical documentation to justify it over more specific alternatives. The CDC/NCHS ICD-10-CM web tool lists R61 with the following inclusion and exclusion notes that directly affect correct application.

Night sweats represent one of the more debated inclusions. Coding references note that R61 may be applied when night sweats are the presenting complaint and no specific underlying diagnosis has been documented.

However, the American Hospital Association’s Coding Clinic has not issued an unambiguous directive on this point. Verify with your Medicare Administrative Contractor (MAC) or coding compliance team before using R61 as the sole code for isolated nocturnal sweating complaints.

ICD-10 Code R61 vs L74.5: Generalized vs focal hyperhidrosis

The single most common coding error in hyperhidrosis billing is applying R61 when L74.5x is more specific. Most dermatology and aesthetic practices see far more focal presentations (axillary sweating, palmar sweating) than true generalized cases, yet R61 gets defaulted to out of habit.

The table below shows the full L74.5x subcode structure alongside R61 so you can select the right code at the point of documentation.

The decision rule: if documentation describes sweating limited to one or two anatomical sites, use the matching L74.5x subcode. If sweating is diffuse, body-wide, or the record does not specify a focal pattern, R61 is appropriate. Never use R61 and a focal L74.5x code simultaneously for the same encounter.

Primary vs secondary hyperhidrosis: Coding implications

The primary/secondary distinction affects more than code selection. It determines sequencing, which in turn affects how payers evaluate medical necessity. Coders and clinicians using dermatology EMR software should ensure documentation supports whichever path applies.

Primary hyperhidrosis has no identifiable underlying cause. It is idiopathic, often genetic, and typically focal. For generalized primary presentations, R61 is appropriate when no focal site can be documented.

Secondary hyperhidrosis results from a systemic condition, medication, or other identifiable cause. Per ICD-10-CM Official Guidelines, when the etiology is established, code the underlying condition first and use R61 as an additional code. Below are the most common secondary causes and their own ICD-10 codes.

When the cause is uncertain or a workup is in progress, R61 may serve as the principal diagnosis for that encounter. Document explicitly that the etiology is “under investigation” to support this sequencing decision. The same symptom-first sequencing approach applies to other Chapter 18 codes, including R54, when the underlying cause has not yet been confirmed.

CPT codes commonly paired with R61

Hyperhidrosis treatment billing requires pairing R61 (or the appropriate L74.5x code) with a matching CPT procedure code. Per the AAPC Codify ICD-10-CM reference, the most frequently billed combinations are listed below. Coverage varies by payer, so document medical necessity for each.

Botox for hyperhidrosis: ICD-10 and CPT billing

Botulinum toxin injection (onabotulinumtoxinA) carries an FDA-approved indication for severe primary axillary hyperhidrosis specifically. This is a critical billing distinction: the FDA approval is for primary axillary hyperhidrosis (L74.510), not for generalized hyperhidrosis (R61). Billing CPT 64650 against R61 without supporting documentation of prior treatment failure and clinical severity significantly increases denial risk.

When axillary sweating is part of a broader generalized presentation, coding L74.510 as the primary code with R61 as additional may better reflect the clinical picture and support medical necessity for the botulinum injection. Document the HDSS (Hyperhidrosis Disease Severity Scale) score, prior antiperspirant failure, and the specific treatment area to support the claim.

Medical necessity and documentation requirements for R61

Payers reviewing R61 claims look for a documented clinical picture that rules out focal hyperhidrosis and establishes the medical impact on the patient. Medicare Administrative Contractors (MACs) may have regional Local Coverage Determinations (LCDs) that set specific thresholds.

Prior authorization requirements vary by plan year and insurer, so verify current policy before treating. The WHO ICD-10 classification browser provides the international coding context, while MAC policy governs US reimbursement decisions.

Building consistent documentation habits across your team reduces audit exposure. Digital intake forms and structured clinical note templates make it easier to capture the required elements every time. For broader HIPAA compliance requirements for medical offices, ensure documentation practices meet both coding and privacy standards.

• Symptom description: document that sweating is generalized (multiple body regions), not confined to a single site
• Duration and frequency: how long the patient has experienced symptoms and how often episodes occur
• Severity scale: HDSS score or equivalent patient-reported severity measure (HDSS 3 or 4 typically required for treatment approval)
• Affected daily function: describe functional impairment (work, social, clothing choices)
• Prior treatment history: document trials of prescription-strength antiperspirants (aluminum chloride) before proceeding to injection or procedural therapy
• Exclusion of focal pattern: note that no specific anatomical focus was identified, supporting the use of R61 over L74.5x
• Exclusion of underlying cause: if secondary causes were ruled out (thyroid function tested, medication review completed), document this; if still under investigation, note the workup in progress

Missing even two of these elements is a common reason R61 claims are returned. Compliance management tools that flag incomplete clinical records before claim submission catch missing documentation before it turns into a denial. Referencing HIPAA compliance guidance for healthcare practices is also relevant when storing and transmitting hyperhidrosis patient records digitally.

ICD-10 codes for related sweating conditions

R61 does not exist in isolation. Coders regularly encounter adjacent sweating conditions that need their own code or a companion code.

The reference table below covers the codes most often confused with or documented alongside R61, with the distinguishing clinical factor for each. This same distinguish-by-clinical-factor approach carries over to other integumentary procedure codes, including CPT 11471, which covers a different sweat-gland-adjacent condition.

How Pabau supports ICD-10 R61 coding and billing

Dermatology and aesthetic practices using Pabau can search ICD-10-CM codes directly inside the patient record without switching to a separate lookup tool. When documenting a hyperhidrosis encounter, the coder or clinician types “R61” or “generalized hyperhidrosis” into the diagnosis field and the system returns the code with its full description for confirmation before saving.

Structured clinical note templates for hyperhidrosis can be built inside Pabau to capture the documentation elements payers require: HDSS score, treatment history, affected body areas, and prior therapy failure. This makes it less likely a clinician misses a required field under time pressure.

Clinical client records in Pabau link the diagnosis code, treatment record, and billing data in one place, which reduces the risk of a mismatch between what was treated and what was coded.

For practices managing the full billing cycle, Pabau’s claims management software connects the clinical record directly to the claim submission workflow, flagging incomplete documentation before a claim is submitted. This is particularly useful for R61 claims where payer scrutiny is higher. Patient care management workflows built around consistent ICD-10 documentation also reduce rework when a claim is queried.

Reduce ICD-10 coding errors across your practice

Pabau's built-in ICD-10 code search, structured documentation templates, and claims management tools help dermatology and skin care practices submit accurate R61 and L74.5x claims the first time.

Book a demo

Conclusion

R61 is a straightforward code when the clinical documentation is right. The problems arise at the boundaries: using R61 instead of a more specific L74.5x code, missing the secondary-cause sequencing rule, and submitting without a severity score or prior-treatment history. Get those three elements right and most R61 denials disappear.

Pabau helps practice teams build consistent documentation habits that support accurate billing, the same structured approach that supports coding accuracy for codes like M72.8. To see how Pabau handles diagnosis coding, documentation, and claims in one platform, book a demo.

Continue your research

Need a structured clinical documentation framework? Safer clinical notes guide walks through documentation principles that reduce audit risk across all ICD-10 code types.

Managing dermatology billing across multiple locations? Dermatology EMR software covers how Pabau supports multi-site dermatology coding and record-keeping workflows.

Need billing guidance for a related procedure code? CPT 15101 covers split-thickness autograft billing considerations that follow similar documentation principles.

Frequently Asked Questions